SecBot SecBot

CNTA

Centessa Pharmaceuticals plc
Nasdaq· Pharmaceutical Preparations· Inc. X0· CIK 0001847903 Biotech & Drug Discovery
No price
Median target
$39.00
range $38.00–45.00
Short interest
1.61M
−37.4%
Days to cover
1.2
at average volume
Insider net
$0.00
0 buyers · 2 sellers · since Jun 24
New fund stakes
0
Q2 2026 13F · 30 exits
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 5 reports · latest
Balance 3 bearish · 2 bullish oldest → newest, height = score
Avg score ·High conf. 5/5

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersMIXED

    No open-market sales.

  • InstitutionsBEARISH

    Q2 2026: 0 added (0 new), 30 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.392 → −$0.390 over 90 days. 2 up, 1 down in 30 days.

  • Short sellersCOVERING

    Short interest −37.4% to 1.61M shares. 1.2 days to cover.

Who's buying

13F· Q2 2026
0
new positions
30
exits

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Apr 2026
Recent actions
DateFirmActionRating
Apr 20, 2026Wells Fargo
DOWNGRADE
DOWNGRADEEqual-Weight
Apr 2, 2026Guggenheim
DOWNGRADE
DOWNGRADENeutral
Apr 1, 2026Leerink Partners
DOWNGRADE
DOWNGRADEMarket Perform
Mar 31, 2026Wolfe Research
DOWNGRADE
DOWNGRADEPeer Perform
Mar 31, 2026Needham
DOWNGRADE
DOWNGRADEHold
Feb 24, 2026Wolfe Research
INITIATE
INITIATEOutperform

Insider ledger

Form 4
$0
bought · 0 insiders
$0
sold · 2 insiders
DateInsiderTypeValue
Jun 24, 2026
Stuckley Carol
Director
Jun 24, 2026
TO ISSUER208,474 sh
Jun 24, 2026
Weinhoff Gregory M
Chief Business Officer
Jun 24, 2026
TO ISSUER65,925 sh
Jun 24, 2026
HUSSAIN IQBAL J
Chief Legal Officer
Jun 24, 2026
TO ISSUER221,559 sh
Jun 24, 2026
ZBAR BRETT I W
Director
Jun 24, 2026
TO ISSUER64,570 sh
Jun 24, 2026
GOYAL ARJUN
Director
Jun 24, 2026
TO ISSUER462,585 sh
Jun 24, 2026
Kulkarni Samarth
Director
Jun 24, 2026
TO ISSUER208,474 sh
Jun 24, 2026
Hukkelhoven Mathias
Director
Jun 24, 2026
TO ISSUER96,000 sh
Jun 24, 2026
Weinhoff Gregory M
Chief Business Officer
Jun 24, 2026
TO ISSUER584,321 sh

Earnings setup

Estimates
−$0.39
EPS estimate, this quarter
+0%
estimate change, 90 days
2↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Next FY-$1.78-$2.06–-$1.30+6.2%$28.6M
Next Q-$0.39-$0.39–-$0.39+11.0%$0.00
Current Q-$0.39-$0.39–-$0.39+8.0%$0.00
Current FY-$1.56-$1.56–-$1.56+0.0%$0.00

Short side

FINRA· Jun 15, 2026
1,609,679
shares short
-37.4%
vs prior settlement
1.2
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 6, 2026 Earnings calendar
CNTA Q3 2026 Earnings Scheduled · 2026-11-06
Jul 6, 2026 SEC
Centessa Pharmaceuticals filed a Form 15-12G on July 6, 2026, to voluntarily deregister its ordinary shares and…
15-12G · Impact 7/10
Jun 30, 2026 Inst.
FARALLON CAPITAL MANAGEMENT, L.L.C. · EXIT
0 shares ($0.00)
Jun 30, 2026 Inst.
JPMORGAN CHASE & CO · EXIT
0 shares ($0.00)
Jun 24, 2026 Insider
Stuckley Carol disposed of 208,474 shares
Director
Jun 24, 2026 Insider
Weinhoff Gregory M disposed of 65,925 shares
Chief Business Officer
Jun 24, 2026 Insider
HUSSAIN IQBAL J disposed of 221,559 shares
Chief Legal Officer
Apr 17, 2026 SEC
Centessa Pharmaceuticals (CNTA) is being acquired by Eli Lilly (LILY) in a $7.8B deal structured as a Scheme of…
PREM14A · Impact 9/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Nov 6, 2026
Earnings date
CNTA Q3 2026 Earnings Scheduled · 2026-11-06
Nov 3, 2026
Earnings date
CNTA Q3 2026 Earnings Scheduled · 2026-11-03
Aug 10, 2026
Earnings date
CNTA Q2 2026 Earnings Scheduled, 2026-08-10
Jun 22, 2026
M&A
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
BOSTON and LONDON, June 22, 2026 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of…
May 12, 2026
Earnings date
CNTA Q1 2026 Earnings Scheduled, 2026-05-12

SecBot reports

5 filings · 2 bullish · 3 bearish
All CNTA filing & press-release reports (5)